aztreonam has been researched along with clindamycin in 51 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 24 (47.06) | 18.7374 |
1990's | 17 (33.33) | 18.2507 |
2000's | 5 (9.80) | 29.6817 |
2010's | 4 (7.84) | 24.3611 |
2020's | 1 (1.96) | 2.80 |
Authors | Studies |
---|---|
Beceiro, A; Bou, G; Canle, D; Fernández, A; Lasa, I; Latasa, C; Mallo, S; Molina, F; Pérez, A; Pérez, S; Poza, M; Tomás, Mdel M; Villanueva, R | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Goto, J | 1 |
Canu, L; Casula, G; Deriu, IP; Scintu, F | 1 |
Flink, JR; Heaton, AH; Wagner, BK | 1 |
Chimura, T; Funayama, T; Kanasugi, H; Miyata, R; Morisaki, N; Oono, T; Saitou, N; Sakai, Y; Satou, S; Takahashi, H | 1 |
Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Nakane, Y; Oda, S; Suzuki, Y; Yokota, N | 1 |
Baltch, AL; Conroy, JV; Hammer, MC; Michelsen, PB; Smith, RP | 1 |
Aoki, N; Hirashima, K; Miura, Y; Mizoguchi, H; Mutoh, Y; Nomura, T; Takaku, F; Toyama, K; Urabe, A; Yamaguchi, H | 1 |
Horiuchi, A; Kageyama, T; Kanamaru, A; Kitani, T; Masaoka, T; Nagai, K; Takemoto, Y; Tatsumi, N; Yasunaga, K; Yonezawa, T | 1 |
Fujita, N; Inaba, T; Itoh, K; Murakami, S; Nakagawa, M; Oku, N; Shimazaki, C; Ura, Y | 1 |
Chimura, T; Hirayama, T; Matsuo, M; Morisaki, N | 1 |
Birolini, D; de Souza, OS; Moraes, MF | 1 |
Ramirez-Ronda, CH; Rivera-Vazquez, CR; Rodriguez, JR; Saavedra, S | 1 |
Abe, T; Horiike, S; Inazawa, J; Misawa, S; Nakagawa, H; Nishigaki, H; Okuda, T; Tanaka, S; Taniwaki, M; Tsuda, S | 1 |
Kager, L; Malmborg, AS; Nord, CE | 1 |
Dodson, MG; Faro, S; Gentry, LO | 1 |
Baltch, AL; Bassey, C; Fanciullo, G; Smith, RP | 1 |
Bellantone, R; Bossola, M; Crucitti, F; Doglietto, GB; Pacelli, F; Ratto, C; Sofo, L | 1 |
Amarisse, C; Baldi, F; Gallo, A; Goglia, R; Levantesi, MT; Pinna, GF; Presutti, P | 1 |
Bollinger, M; Greenberg, RN; Ojile, JM; Reilly, PM; Weinandt, WJ; Wilson, KM | 1 |
Craus, W; Formato, A; Mozzillo, N; Ottaviano, A; Romano, A | 1 |
Bosso, JA; Marble, DA; Townsend, RJ | 2 |
Duff, P | 1 |
Appleman, MD; Berne, TV; Chenella, FC; Gill, MA; Heseltine, PN; Yellin, AE | 1 |
Bonner, DP; Clark, JM; Fernandes, PB; Kao, CC; Sykes, RB; Weinberg, DS | 1 |
Becker, A; Burdge, RE; Ellington, LL; Greenberg, RN; Perry, CR; Vossen, MK | 1 |
Blanco, JD; Gibbs, RS; Lipscomb, KA; St Clair, PJ | 1 |
Aldridge, KE; Cole, C; Crapanzano, JC; Pastorek, JG | 1 |
Nevárez, M; Ramírez-Ronda, CH; Rodríguez, JR | 1 |
James, MJ; Riley, CM | 1 |
Fass, RJ; Helsel, VL | 1 |
Adamovics, J; Creasey, WA; Dhruv, R; Platt, TB; Sugerman, AA | 1 |
Adams, RB; Pruett, TL; Sawyer, RG | 1 |
Barboza, E; del Castillo, M; Gotuzzo, E; Yi, A | 1 |
Dodson, MG | 1 |
Boucher, BA; Charland, SL; Croce, MA; Fabian, TC; Hess, MM; Rodman, JH; Wilson, RS; Wilson, SE | 1 |
de Groot, HG; Hustinx, PA; Lampe, AS; Oosterwijk, WM | 1 |
Benjamin, RS; Escalante, C; Fender, A; Hughes, P; Kennedy, K; Loewy, J; Manzullo, E; Moreland, B; Rolston, K; Rubenstein, EB | 1 |
Aoki, I; Aoki, N; Arimori, S; Asano, S; Hirai, H; Hirashima, K; Hirose, S; Ikeda, Y; Kamakura, M; Kuraishi, Y; Masuda, M; Miura, Y; Mizoguchi, H; Mori, M; Muto, Y; Omine, M; Saito, T; Shinbo, T; Shirai, T; Takaku, F; Togawa, A; Toyama, K; Tsuruoka, N; Urabe, A; Yaguchi, M | 1 |
Abi-Said, D; Bivins, C; Hachem, R; Hanna, H; Huaringa, A; Raad, I; Sukumaran, A; Thornby, J; Walsh, G; Whimbey, E | 1 |
Blandino, G; Puleo, S; Rodolico, G; Sammartino, R; Scilletta, B; Tempera, G | 1 |
de Argila, D; Gonzalo-Garijo, MA | 1 |
Hurtado Rendon, IS; Pathak, V; Smina, M | 1 |
Dhanasekaran, S; Manoharan, SS; Selvadoss, PP | 1 |
3 review(s) available for aztreonam and clindamycin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pathophysiology and management of postcesarean endomyometritis.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Cephalosporins; Cesarean Section; Clindamycin; Clinical Trials as Topic; Drug Therapy, Combination; Endometritis; Female; Gentamicins; Humans; Moxalactam; Penicillins; Postoperative Complications; Pregnancy; Socioeconomic Factors | 1986 |
Antibiotic regimens for treating acute pelvic inflammatory disease. An evaluation.
Topics: Acute Disease; Anti-Bacterial Agents; Aztreonam; Cefotetan; Cefoxitin; Chlamydia Infections; Chlamydia trachomatis; Clindamycin; Drug Evaluation; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gentamicins; Humans; Pelvic Inflammatory Disease; Tetracycline Resistance | 1994 |
17 trial(s) available for aztreonam and clindamycin
Article | Year |
---|---|
[Clinical effect of the combined use of aztreonam, amikacin and clindamycin in infectious disease in obstetrics and gynecology].
Topics: Adult; Aged; Amikacin; Aztreonam; Bacterial Infections; Clindamycin; Drug Therapy, Combination; Female; Genital Diseases, Female; Humans; Japan; Middle Aged; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies | 1991 |
Randomized trial of combination antibiotic therapy in patients with hematological disorders. Hanshin Study Group of Hematopoietic Disorders and Infection.
Topics: Adolescent; Adult; Aged; Amikacin; Aztreonam; Clindamycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Male; Middle Aged; Multicenter Studies as Topic; Prospective Studies; Randomized Controlled Trials as Topic | 1990 |
Comparison of aztreonam plus clindamycin with tobramycin plus clindamycin in the treatment of intra-abdominal infections.
Topics: Abdomen; Adolescent; Adult; Aged; Aged, 80 and over; Aztreonam; Bacterial Infections; Clindamycin; Clinical Trials as Topic; Cross Infection; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Humans; Male; Middle Aged; Random Allocation; Tobramycin | 1989 |
A comparative analysis of aztreonam + clindamycin versus tobramycin + clindamycin or amikacin + mezlocillin in the treatment of gram-negative lower respiratory tract infections.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Aztreonam; Bacterial Infections; Clindamycin; Clinical Trials as Topic; Cross Infection; Drug Therapy, Combination; Gram-Negative Bacteria; Humans; Male; Mezlocillin; Middle Aged; Pneumonia; Random Allocation; Tobramycin | 1989 |
Systemic perioperative prophylaxis in elective oncological colorectal surgery: cefotetan versus clindamicin plus aztreonam.
Topics: Adult; Aged; Aged, 80 and over; Aztreonam; Cefotetan; Clindamycin; Colorectal Neoplasms; Female; Humans; Infection Control; Infections; Male; Middle Aged; Postoperative Complications; Surgical Wound Infection | 1988 |
Comparison trial of clindamycin with aztreonam or gentamicin in the treatment of postpartum endometritis.
Topics: Adolescent; Adult; Aztreonam; Clindamycin; Clinical Trials as Topic; Drug Therapy, Combination; Endometritis; Female; Gentamicins; Humans; Pregnancy; Puerperal Disorders; Random Allocation | 1987 |
Antibiotic prophylaxis in surgery ranked by patients' risk rates.
Topics: Aztreonam; Clindamycin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Gentamicins; Humans; Postoperative Complications; Prospective Studies; Random Allocation; Risk Factors; Sepsis | 1987 |
Pathophysiology and management of postcesarean endomyometritis.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Cephalosporins; Cesarean Section; Clindamycin; Clinical Trials as Topic; Drug Therapy, Combination; Endometritis; Female; Gentamicins; Humans; Moxalactam; Penicillins; Postoperative Complications; Pregnancy; Socioeconomic Factors | 1986 |
Surgically treated gangrenous or perforated appendicitis. A comparison of aztreonam and clindamycin versus gentamicin and clindamycin.
Topics: Adult; Appendicitis; Aztreonam; Clindamycin; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Gentamicins; Humans; Intestinal Perforation; Male; Peritonitis; Random Allocation; Rupture, Spontaneous | 1987 |
Aztreonam versus gentamicin, each with clindamycin, in the treatment of endometritis.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; Cesarean Section; Clindamycin; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Endometritis; Enterobacteriaceae; Female; Gentamicins; Gram-Negative Aerobic Bacteria; Humans; Postoperative Complications; Pregnancy; Random Allocation | 1985 |
Efficacy and safety of aztreonam-clindamycin versus tobramycin-clindamycin in the treatment of lower respiratory tract infections caused by aerobic gram-negative bacilli.
Topics: Aged; Anti-Bacterial Agents; Aztreonam; Bacteria, Aerobic; Clindamycin; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Respiratory Tract Infections; Tobramycin | 1985 |
Clindamycin plus amikacin versus clindamycin plus aztreonam in established intraabdominal infections.
Topics: Abdomen; Abscess; Adult; Amikacin; Appendicitis; Aztreonam; Bacterial Infections; Clindamycin; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Intestinal Perforation; Male; Prospective Studies; Single-Blind Method | 1994 |
Superiority of aztreonam/clindamycin compared with gentamicin/clindamycin in patients with penetrating abdominal trauma.
Topics: Abdominal Injuries; Adult; Aztreonam; Bacterial Infections; Blood Transfusion; Clindamycin; Colon; Double-Blind Method; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Prospective Studies; Risk Factors; Wounds, Gunshot; Wounds, Penetrating | 1994 |
Comparison of imipenem/cilastatin with the combination of aztreonam and clindamycin in the treatment of intra-abdominal infections.
Topics: Abdomen; Adolescent; Adult; Aged; Aged, 80 and over; Aztreonam; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Clindamycin; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Premedication; Prospective Studies; Surgical Wound Infection; Treatment Failure | 1993 |
Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer.
Topics: Administration, Oral; Adolescent; Adult; Aged; Ambulatory Care; Aztreonam; Bacteremia; Bacterial Infections; Ciprofloxacin; Clindamycin; Female; Fever; Humans; Injections, Intravenous; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies | 1993 |
Effect of recombinant human granulocyte colony-stimulating factor on combination therapy with aztreonam and clindamycin for infections in neutropenic patients with hematologic diseases.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Aztreonam; Clindamycin; Drug Therapy, Combination; Granulocyte Colony-Stimulating Factor; Humans; Leukemia; Lymphoma; Middle Aged; Monobactams; Neutropenia; Pneumonia; Recombinant Proteins; Sepsis; Treatment Outcome | 1996 |
Treatment of nosocomial postoperative pneumonia in cancer patients: a prospective randomized study.
Topics: Aged; Amikacin; Aztreonam; Chi-Square Distribution; Clindamycin; Cross Infection; Drug Therapy, Combination; Humans; Middle Aged; Neoplasms; Opportunistic Infections; Penicillanic Acid; Piperacillin; Pneumonia, Bacterial; Postoperative Complications; Prognosis; Prospective Studies; Tazobactam | 2001 |
32 other study(ies) available for aztreonam and clindamycin
Article | Year |
---|---|
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
Topics: Bacterial Proteins; Base Sequence; beta-Lactamases; Carrier Proteins; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, MDR; Genetic Vectors; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Aerobic and anaerobic bacterial interactions in the development of anaerobic bacterial pneumonia.
Topics: Animals; Aztreonam; Bacteroides fragilis; Clindamycin; Escherichia coli; Female; Guinea Pigs; Injections, Intraperitoneal; Lung; Neutrophils; Phagocytosis; Pneumonia | 1992 |
[Mechanical and antibiotic preparation and infections in colorectal surgery. Comparison of 2 methods of orthograde lavage].
Topics: Adult; Aged; Anti-Bacterial Agents; Aztreonam; Cephalosporins; Clindamycin; Colectomy; Colon; Colostomy; Female; Humans; Male; Middle Aged; Premedication; Rectum; Surgical Wound Infection; Therapeutic Irrigation | 1992 |
Cefotetan disodium-induced hemolytic anemia.
Topics: Anemia, Hemolytic; Aztreonam; Cefotetan; Clindamycin; Female; Humans; Injections, Intravenous; Middle Aged; Plasmapheresis | 1992 |
[Combined antibacterial activity of aztreonam and clindamycin against clinically isolated strains].
Topics: Aztreonam; Bacteria; Clindamycin; Drug Therapy, Combination; Microbial Sensitivity Tests | 1991 |
Antimicrobial effect of clindamycin in combination with aztreonam or aminoglycosides against Klebsiella spp.
Topics: Aminoglycosides; Aztreonam; Clindamycin; Drug Therapy, Combination; Klebsiella; Microbial Sensitivity Tests; Species Specificity | 1991 |
[Combination therapy with aztreonam and clindamycin on severe infections accompanying neutropenic patients with hematological disorders].
Topics: Adult; Aged; Aztreonam; Bacterial Infections; Clindamycin; Drug Evaluation; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Infusions, Intravenous; Male; Middle Aged; Neutropenia | 1990 |
[Effect of combination therapy with carumonam and clindamycin on severe infections in patients with hematologic malignancies].
Topics: Adult; Aged; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Clindamycin; Drug Evaluation; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Infusions, Intravenous; Male; Middle Aged | 1990 |
[Clinical effects of cefodizime against infectious diseases in obstetrics and gynecology].
Topics: Adolescent; Adult; Aged; Aztreonam; Bacteria; Bacterial Infections; Cefotaxime; Clindamycin; Drug Evaluation; Female; Genital Diseases, Female; Humans; Infusions, Intravenous; Middle Aged | 1989 |
[Clinical evaluation of a combination therapy with aztreonam and clindamycin for severe infections in leukemia and related disorders].
Topics: Adult; Aged; Aged, 80 and over; Aztreonam; Bacterial Infections; Clindamycin; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Leukemia; Leukocyte Count; Male; Middle Aged | 1989 |
Effects of antimicrobial prophylaxis on colonization resistance.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aztreonam; Bacteria; Cilastatin; Cilastatin, Imipenem Drug Combination; Clindamycin; Colon; Cyclopropanes; Drug Combinations; Female; Humans; Imipenem; Male; Middle Aged; Premedication; Thienamycins | 1988 |
Treatment of acute pelvic inflammatory disease with aztreonam, a new monocyclic beta-lactam antibiotic, and clindamycin.
Topics: Adult; Aztreonam; Body Temperature; Cervix Uteri; Clindamycin; Drug Evaluation; Drug Therapy, Combination; Endometrium; Female; Humans; Leukocyte Count; Liver Function Tests; Neisseria gonorrhoeae; Pain; Pelvic Inflammatory Disease | 1986 |
In-vitro antimicrobial activity of enoxacin in combination with eight other antibiotics against Pseudomonas aeruginosa, Enterobacteriaceae and Staphylococcus aureus.
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Cefsulodin; Clindamycin; Drug Combinations; Drug Synergism; Enoxacin; Enterobacteriaceae; Microbial Sensitivity Tests; Moxalactam; Naphthyridines; Oxacillin; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Vancomycin | 1987 |
[Prophylaxis of surgical infections. Short-term administration of aztreonam. Personal cases].
Topics: Adult; Aged; Aztreonam; Clindamycin; Female; Humans; Male; Middle Aged; Surgical Wound Infection | 1988 |
Compatibility of clindamycin phosphate with aztreonam in polypropylene syringes and with cefoperazone sodium, cefonicid sodium, and cefuroxime sodium in partial-fill glass bottles.
Topics: Aztreonam; Cefamandole; Cefonicid; Cefoperazone; Cefuroxime; Cephalosporins; Clindamycin; Drug Combinations; Drug Incompatibility; Drug Packaging; Drug Stability; Syringes | 1988 |
Stability of clindamycin phosphate with aztreonam, ceftazidime sodium, ceftriaxone sodium, or piperacillin sodium in two intravenous solutions.
Topics: Aztreonam; Ceftazidime; Ceftriaxone; Clindamycin; Drug Stability; Hydrogen-Ion Concentration; Injections, Intravenous; Piperacillin; Solutions; Temperature | 1986 |
Evaluation of aztreonam, cefoperazone, latamoxef and ceftazidime in the hamster colitis model.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; Bacterial Toxins; Cecum; Cefoperazone; Ceftazidime; Clindamycin; Colitis; Cricetinae; Disease Models, Animal; Drug Evaluation; Injections, Intraperitoneal; Male; Mesocricetus; Moxalactam | 1986 |
Antibiotic stability in an implantable pump.
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Clindamycin; Drug Stability; Gentamicins; Humans; Infusion Pumps; Microbial Sensitivity Tests; Netilmicin; Osteomyelitis; Tobramycin | 1986 |
Aztreonam plus clindamycin as therapy for pelvic infections in women.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Clindamycin; Drug Evaluation; Drug Therapy, Combination; Endometritis; Female; Gram-Negative Aerobic Bacteria; Humans; Parametritis; Pelvic Inflammatory Disease | 1985 |
Stability of intravenous admixtures of aztreonam and clindamycin phosphate.
Topics: Ampicillin; Aztreonam; Chromatography, High Pressure Liquid; Clindamycin; Drug Combinations; Drug Stability; Hydrogen-Ion Concentration; Injections, Intravenous; Spectrophotometry, Ultraviolet; Temperature | 1985 |
In vitro activity of carumonam.
Topics: Anti-Bacterial Agents; Aztreonam; Clindamycin; Drug Synergism; Enterobacteriaceae; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Nafcillin; Piperacillin; Tobramycin | 1985 |
Pharmacokinetic interaction of aztreonam with other antibiotics.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; Cephradine; Clindamycin; Drug Interactions; Gentamicins; Humans; Kinetics; Male; Metronidazole; Nafcillin | 1984 |
Aztreonam vs. gentamicin in experimental peritonitis and intra-abdominal abscess formation.
Topics: Abdominal Abscess; Animals; Aztreonam; Bacteroides fragilis; Bacteroides Infections; beta-Lactam Resistance; Clindamycin; Colony Count, Microbial; Drug Combinations; Escherichia coli; Escherichia coli Infections; Gentamicins; Hydrogen-Ion Concentration; Hypoxia; Male; Mice; Mice, Inbred BALB C; Penicillin Resistance; Peritonitis | 1994 |
[Reevaluation of current antimicrobials. Series 15: aztreonam. Discussion].
Topics: Aztreonam; Bacteria; Bacterial Infections; Clindamycin; Drug Resistance, Microbial; Drug Therapy, Combination; Humans | 1994 |
Colorectal surgery: short-term prophylaxis with aztreonam plus clindamycin versus gentamicin plus clindamycin.
Topics: Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Aztreonam; Bacterial Infections; Clindamycin; Clinical Trials as Topic; Colectomy; Colorectal Neoplasms; Digestive System Surgical Procedures; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Middle Aged; Surgical Wound Infection | 1989 |
Erythroderma due to aztreonam and clindamycin.
Topics: Aged; Aztreonam; Clindamycin; Dermatitis, Exfoliative; Female; Humans; Injections, Intravenous; Intradermal Tests | 2006 |
Necrotizing pneumonia caused by group C streptococci in a young adult.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; Clindamycin; Drug Therapy, Combination; Humans; Lung Abscess; Male; Necrosis; Pleural Effusion; Pneumonia; Streptococcal Infections; Streptococcus; Tomography, X-Ray Computed | 2012 |
Anti-Fungal Potential of Structurally Diverse FDA-Approved Therapeutics Targeting Secreted Aspartyl Proteinase (SAP) of Candida albicans: an In Silico Drug Repurposing Approach.
Topics: Anti-Bacterial Agents; Aspartic Acid Endopeptidases; Aspartic Acid Proteases; Aztreonam; Candida albicans; Candidiasis; Clindamycin; Drug Repositioning; Humans; Meropenem; Metronidazole | 2023 |